Sysmex America, Inc.
9
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.1%
1 terminated/withdrawn out of 9 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Association of Platelet Parameters With Bleeding Severity in Children With ITP
Role: collaborator
Magnetic Tracer in the Sentinel Node Procedure in Breast Cancer: the Non-radioactive Alternative for Radio-isotopes
Role: collaborator
Sentinel Lymph Node Total Tumoral Load as a Predictor of Non Sentinel Node Involvement in Early Breast Cancer
Role: collaborator
IDENTIFICATION OF SENTINEL NODE(S) IN BREAST CANCER
Role: collaborator
Testing of Different Methods for Determining Whether Breast Cancer Has Spread to the Lymph Nodes
Role: collaborator
Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section Histopathology
Role: lead
Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy
Role: lead
Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer
Role: lead
Clinical Evaluation of OSNA Breast Cancer System to Test Sentinel Lymph Nodes From Patients With Breast Cancer
Role: lead
All 9 trials loaded